Haleon plc (HLN) - Utang jangka dawa marang modal

Lambang korporat lan logo haleon.com (HLN)

Haleon plc, a leader in the over-the-counter and hygiene segment, is implementing eco-friendly packaging made from recyclable plastic and optimizing water consumption. The business relies on partnerships with digital health services and the targeted acquisition of niche brands. The share price history on GURU.Markets, where the individual long-term debt metric is 0.39, is supplemented by data on a stable workforce and the hiring of e-commerce experts.

Haleon Group (HLN) - Utang jangka dawa marang ekuitas saka 28.04.2023 nganti 31.10.2026
Barang utama haleon.com

To minimize debt risks, it is essential for investors to monitor 0.39, which reflects the share of loans with a maturity of over one year within the equity structure. Haleon plc (HLN) transition to renewable energy and sustainable packaging requires stable financing; therefore, analyzing the ratio of long-term loans to equity confirms the company's ability to sustain capital-intensive modernization without threatening the business's financial stability.

Perusahaan pesaing

KVUE: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal VRNA|Utang jangka dawa marang modal Jyong Bio (MENS)|Utang jangka dawa marang ekuitas Ligand Pharmaceuticals LGND|Koefisien utang jangka dawa marang modal AMRX|PRGO - Utang jangka dawa marang ekuitas|Alvotech S.A. (ALVO) - Rasio utang jangka dawa marang ekuitas|LQDA: Utang jangka dawa marang modal|Galapagos Corp (GLPG) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas ANIP|MNKD: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX - Kewajiban jangka dawa marang modal|ARS Pharma - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal TBPH (Theravance Corp)|Aquestive Therapeutics - Utang jangka dawa marang modal|Koefisien utang jangka dawa marang modal SCPH (scPharmaceuticals Inc.)|TECX: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Tonix Pharma (TNXP)|Utang jangka dawa marang ekuitas SXT Pharmaceuticals|EPRX: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal BHST|EXOZ (invizyne.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal ORMP (Oramed Pharmaceuticals Inc.)|Utang jangka dawa marang modal Entera Bio Ltd ENTX|HYFT - Utang jangka dawa marang ekuitas|ABVC: Utang jangka dawa marang ekuitas|CPIX: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal quantumbiopharma.com (QNTM)|Utang jangka dawa marang ekuitas FibroGen|Kewajiban jangka dawa marang modal Telomir Pharmaceuticals Inc TELO|Utang jangka dawa marang ekuitas Rani Therapeutics (RANI)|synergychc.com - Rasio utang jangka dawa marang modal|Rallybio - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal LEXX|PULM - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang ekuitas PTHL|aptorumgroup.com (APM) - Utang jangka dawa marang ekuitas|LYRA (Lyra Therapeutics Inc) - Utang jangka dawa marang ekuitas|IBO (Impact BioMedical Inc) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas TNF Pharma (TNFA)|Utang jangka dawa marang modal YCBD|PRFX (PainReform Ltd) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Altamira Therapeutics Ltd. CYTO|Lipella Pharma - Utang jangka dawa marang ekuitas|OPTN - Utang jangka dawa marang ekuitas|PIRS (pieris.com) - Rasio utang jangka dawa marang modal|Procaps (PROC) - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang ekuitas PTPI (Petros Pharmaceuticals Inc)|QLI (Qilian International Holding Group Limited) - Utang jangka dawa marang modal|SLRN: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal TFFP